Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofarabine With Cytarabine for MRD Positive Leukemia

NCT01158885 is registered in ClinicalTrials.gov with Therapeutic Advances in Childhood Leukemia Consortium as lead sponsor.

NCT NCT01158885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofarabine With Cytarabine for MRD Positive Leukemia
Lead sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2010
Completion date
October 24, 2012
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoblastic, acute, leukemia, myelogenous, acute, minimal residual disease